NSAIDs use may cut breast cancer risk
This article was originally published in The Tan Sheet
Executive SummaryNon-steroidal anti-inflammatory drug use, including aspirin and ibuprofen, is associated with a reduced risk of breast cancer, according to a meta-analysis published Oct. 7 in the Journal of National Cancer Institute. The review of 38 studies conducted between January 1966 and July 2008 found women using NSAIDs were 12 percent less likely to develop breast cancer than women who did not. Ibuprofen use reduced the risk by 21 percent and aspirin use by 13 percent. The study did not find that higher doses or longer duration - especially of aspirin or ibuprofen - further reduced the risk of breast cancer. Researchers, led by Bahi Takkouche at the University of Santiago de Compostela in Spain, acknowledge weaknesses in the meta-analysis, including not considering other drugs participants took
You may also be interested in...
Top-level personnel movement continues at pharma firms in India, with Cipla now appointing an ex-Amneal executive as its Chief Scientific Officer, while Abbott has effected a rejig at the helm.
Indian pharmaceutical companies will soon be asked to seek a no objection certificate for the export of 12 APIs and their formulations, as the country deals with Chinese raw material supply disruptions on the back of the coronavirus crisis. However, the move is not expected to impact the export quantum for now.